Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chlorothiazide
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Cadila Pharmaceuticals | Wellcome Trust | Canadian Institutes of Health Research | Heart and Stroke Foundation Ontario
Deal Size : Inapplicable
Deal Type : Inapplicable
The International Polycap Study 3 (TIPS-3)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 20, 2012
Lead Product(s) : Chlorothiazide
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Cadila Pharmaceuticals | Wellcome Trust | Canadian Institutes of Health Research | Heart and Stroke Foundation Ontario
Deal Size : Inapplicable
Deal Type : Inapplicable